Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-06-06 @ 9:55 AM
Study NCT ID:
NCT01719003
Status:
COMPLETED
Last Update Posted:
2016-02-19
First Post:
2012-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Sponsor:
Boehringer Ingelheim
Organization: